[Review of today's treatment of bronchial small cell anaplastic cancers (author's transl)].
The median survival time of untreated patients with small cell anaplastic carcinoma of the lung does not exceed three months. An important improvement in survival and disease-free period has been achieved by some new therapeutic combinations including chemotherapy alone or radiotherapy and chemotherapy. These recent results are reviewed in this paper, and a new treatment schedule is presented.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008297:Male
D000970:Antineoplastic Agents
Revue de l'état actuel du traitement des cancers anaplasiques bronchiques à petites cellules.